Stock Research for ADXS

ADXS
Current Price

$3.0450


Latest Update: 2017-12-14 16:00:00

High
$ 3.0500
Low
$ 3.0300
Close
$ 3.0500
Volume
63151
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

ADXS Stock Chart & Research Data

The ADXS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADXS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ADXS Due diligence Resources & Stock Charts

The ADXS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ADXS Detailed Price Forecast - CNN Money CNN View ADXS Detailed Summary - Google Finance
Yahoo View ADXS Detailed Summary - Yahoo! Finance Zacks View ADXS Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ADXS Trends & Analysis - Trade-Ideas Barrons View ADXS Major Holders - Barrons
NASDAQ View ADXS Call Transcripts - NASDAQ Seeking View ADXS Breaking News & Analysis - Seeking Alpha
Spotlight View ADXS Annual Report - CompanySpotlight.com OTC Report View ADXS OTC Short Report - OTCShortReport.com
TradeKing View ADXS Fundamentals - TradeKing Charts View ADXS SEC Filings - Bar Chart
WSJ View Historical Prices for ADXS - The WSJ Morningstar View Performance/Total Return for ADXS - Morningstar
MarketWatch View the Analyst Estimates for ADXS - MarketWatch CNBC View the Earnings History for ADXS - CNBC
StockMarketWatch View the ADXS Earnings - StockMarketWatch MacroAxis View ADXS Buy or Sell Recommendations - MacroAxis
Bullish View the ADXS Bullish Patterns - American Bulls Short Pains View ADXS Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ADXS Stock Mentions - StockTwits PennyStocks View ADXS Stock Mentions - PennyStockTweets
Twitter View ADXS Stock Mentions - Twitter Invest Hub View ADXS Investment Forum News - Investor Hub
Yahoo View ADXS Stock Mentions - Yahoo! Message Board Seeking Alpha View ADXS Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for ADXS - SECform4.com Insider Cow View Insider Transactions for ADXS - Insider Cow
CNBC View ADXS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ADXS - OTC Markets
Yahoo View Insider Transactions for ADXS - Yahoo! Finance NASDAQ View Institutional Holdings for ADXS - NASDAQ


Stock Charts

FinViz View ADXS Stock Insight & Charts - FinViz.com StockCharts View ADXS Investment Charts - StockCharts.com
BarChart View ADXS Stock Overview & Charts - BarChart Trading View View ADXS User Generated Charts - Trading View


Latest Financial News for ADXS

Advaxis to Host Business Update and Fiscal Year End 2017 Financial Results Conference Call on December 21, 2017
Posted on Thursday December 14, 2017

Advaxis, Inc.  , a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces that the Company will release financial results for the fiscal year ended October 31, 2017 on Wednesday, December 20, 2017.


Is Advaxis Inc (NASDAQ:ADXS) As Financially Strong As Its Balance Sheet Indicates?
Posted on Wednesday December 13, 2017

Zero-debt allows substantial financial flexibility, especially for small-cap companies like Advaxis Inc (NASDAQ:ADXS), as the company does not have to adhere to strict debt covenants. However, it also faces higherRead More...


Analysis: Positioning to Benefit within Diebold, Liberty TripAdvisor, Paycom Software, First American, Advaxis, and Sanmina — Research Highlights Growth, Revenue, and Consolidated Results
Posted on Wednesday November 22, 2017

NEW YORK, Nov. 22, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Diebold, ...


Advaxis to Present at the Jefferies 2017 London Healthcare Conference
Posted on Thursday November 09, 2017

Advaxis, Inc.  , a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announces that company management will participate in the Jefferies 2017 London Healthcare Conference taking place November 15-16, 2017 in London, UK.


Here's Why Advaxis, Inc. Stock Is Getting Pummeled Today
Motley Fool - Sep 12, 2017
Shares of Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotech developing novel cancer immunotherapies, are sinking after the company provided a business update along with a third-quarter earnings report after the bell yesterday.
Where Do The Chips Fall For Advaxis Going Into Q4 2017? - Seeking Alpha
Advaxis, Inc. (NASDAQ:ADXS) Slumps On Business Update - TheOTCReporter.com (blog)

Advaxis Inc. (ADXS) Soars 6.67% on December 13
Equities.com - Dec 13, 2017
Advaxis Inc. (ADXS) had a good day on the market for Wednesday December 13 as shares jumped 6.67% to close at $3.20. About 719,241 shares traded hands on 2,267 trades for the day, compared with an average daily volume of 756,474 shares out of a total ...
This is what analysts have to say about Advaxis, Inc. (NASDAQ:ADXS) after last ... - Weekly Register
Here's how analysts see Advaxis, Inc. (NASDAQ:ADXS) after this past week. - BZ Weekly

Advaxis: So It's Panic, Then? Where This Thing Is Headed
Seeking Alpha - Oct 30, 2017
Management shakeups, delays in submission, and the backing out of investors have contributed to suppressed shareholder sentiment. The current situation might just be an unparalleled opportunity for speculation.
Advaxis Inc. (ADXS) Soars 6.92% on October 30 - Equities.com

Advaxis to Host Business Update and Fiscal Year End 2017 Financial Results ...
Business Wire (press release) - 15 hours ago
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces that the Company will release financial results for the ...
Analysts See $-0.43 EPS for Advaxis, Inc. (ADXS) - Frisco Fastball
Blackrock Inc. Now Holds $6.9 million Worth Of Advaxis, Inc. (ADXS) - Post Analyst

Enter a stock symbol to view the stock details.